Immunotherapy in Sarcoma: Current Data and Promising Strategies.


Journal

American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting
ISSN: 1548-8756
Titre abrégé: Am Soc Clin Oncol Educ Book
Pays: United States
ID NLM: 101233985

Informations de publication

Date de publication:
Jun 2024
Historique:
medline: 23 5 2024
pubmed: 23 5 2024
entrez: 23 5 2024
Statut: ppublish

Résumé

Traditionally sarcomas have been considered immunologically quiet tumours, with low tumour mutational burden (TMB) and an immunosuppressive tumour microenvironment (TME), consisting of decreased T-cell infiltration and elevated levels of H1F1α, macrophages and neutrophils.

Identifiants

pubmed: 38781557
doi: 10.1200/EDBK_432234
doi:

Substances chimiques

Immune Checkpoint Inhibitors 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

e432234

Auteurs

Georgina E Wood (GE)

University College Hospital of London, London, United Kingdom.

Christian Meyer (C)

Johns Hopkins, Baltimore, MD.

Florent Petitprez (F)

The University of Edinburgh, Edinburgh, Scotland.

Sandra P D'Angelo (SP)

Memorial Sloan Kettering Cancer Center, New York, NY.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH